Sensei Biotherapeutics, Inc. announced that on March 27, 2024, Erin Colgan notified the company of her resignation from all positions with the Company, including as Chief Financial Officer. Ms. Colgan?s resignation is voluntary and will be effective April 10, 2024, and was not related to any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 USD | -14.67% | -4.85% | +126.88% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+126.88% | 39.38M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.42% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- SNSE Stock
- News Sensei Biotherapeutics, Inc.
- Sensei Biotherapeutics, Inc. Announces Resignation of Erin Colgan as Chief Financial Officer, Effective April 10, 2024